Genomic abnormalities as biomarkers and therapeutic targets in acute myeloid leukemia

S Ribeiro, AM Eiring, JS Khorashad - Cancers, 2021 - mdpi.com
Simple Summary AML is a heterogenous malignancy with a variety of underlying genomic
abnormalities. Some of the genetic aberrations in AML have led to the development of …

Degraders: the ultimate weapon against amplified driver kinases in cancer

P Torres-Ayuso, J Brognard - Molecular Pharmacology, 2022 - ASPET
Amplification of pro-oncogenic kinases is a common genetic alteration driving tumorigenic
phenotypes. Cancer cells rely on the amplified kinases to sustain cell proliferation, survival …

Predisposing deleterious variants in the cancer-associated human kinases in the global populations

SA Khan, M Anwar, A Gohar, MR Roosan, DC Hoessli… - Plos one, 2024 - journals.plos.org
Human kinases play essential and diverse roles in the cellular activities of maintaining
homeostasis and growth. Genetic mutations in the genes encoding the kinases (or …

[HTML][HTML] Comprehensive analysis of the relationship between cuproptosis-related genes and esophageal cancer prognosis

H Xu, QC Du, XY Wang, L Zhou, J Wang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Esophageal cancer is one of the most common malignant tumors of the
digestive system, with a 5-year survival rate of 15% to 50%. Cuproptosis, a unique kind of …

Chemoinformatics and machine learning techniques to identify novel inhibitors of the lemur tyrosine kinase-3 receptor involved in breast cancer

F Alrumaihi - Frontiers in Molecular Biosciences, 2024 - frontiersin.org
Breast cancer is still the largest cause of cancer death in women, and around 70% of
primary breast cancer patients are estrogen receptor (ER)-positive, which is the most …

Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein–Protein Binding

ÁL Póti, L Dénes, K Papp, C Bató, Z Bánóczi… - International Journal of …, 2023 - mdpi.com
Protein kinases are key regulators of cell signaling and have been important therapeutic
targets for three decades. ATP-competitive drugs directly inhibit the activity of kinases but …

Developing a framework for the health technology assessment of histology-independent precision oncology therapies

JG Gaultney, JC Bouvy, RH Chapman… - … Health Economics and …, 2021 - Springer
The arrival of precision oncology is challenging the evidence standards under which
technologies are evaluated for regulatory approval as well as for health technology …

Computational POM and DFT evaluation of phycocyanin and its derivatives as a potential anticancer agent

R Sabbahi, MH Youssoufi, K Azzaoui… - Materials Today …, 2023 - Elsevier
Phycocyanin, a pigment-protein found in Spirulina, has been shown to have powerful
biological properties. We developed a computational Petra/Osiris/Molinspiration/Density …

Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics

L Lai, X Chen, G Tian, R Liang, X Chen, Y Qin… - Cancer …, 2022 - journals.sagepub.com
Background Pim-1 is overexpressed in cancer tissues and plays a vital role in
carcinogenesis. However, its clinical significance in cancers is not fully verified by meta …

In search of outliers. Mining for protein kinase inhibitors based on their anti-proliferative NCI-60 cell lines profile

GND Ion, GM Nitulescu - Molecules, 2020 - mdpi.com
Protein kinases play a pivotal role in signal transduction, protein synthesis, cell growth and
proliferation. Their deregulation represents the basis of pathogenesis for numerous …